Arkansas biologics regulations.
Who may administer PRP, exosomes and stem cells in Arkansas, and which agencies to check.

Who may administer biologics in Arkansas?
Only licensed physicians and appropriately credentialed healthcare practitioners are permitted to administer stem cell therapies in Arkansas. Medical doctors, osteopathic physicians, and other licensed providers with advanced training are generally authorized. Arkansas requires MD/DO licensure to administer human tissue products.
Official sources
Arkansas compliance guide.
FDA Compliance
The U.S. Food and Drug Administration (FDA) regulates human cells, tissues, and cellular and tissue-based products (HCT/Ps) under its HCT/P regulatory framework. Providers must ensure that any biologics used meet FDA criteria under the 21 CFR Part 1271 guidelines, including screening, testing, processing, and labeling. Certain exemptions may apply if the product meets criteria for “minimal manipulation” and “homologous use.” Clinics should confirm that their biologic products align with FDA standards to ensure compliance.
Arkansas State Regulations
In Arkansas, clinics must comply with the state’s health department regulations when offering biologics and stem cell treatments. Detailed guidance for Arkansas is available on the Arkansas Department of Health website. While Arkansas follows federal standards, state-specific guidelines may apply, especially around practitioner credentials and patient consent. Understanding and adhering to these state guidelines is key to accessible compliance and establishing a legal framework for biologic services in Arkansas.
Provider Qualifications
Only licensed physicians and appropriately credentialed healthcare practitioners are permitted to administer stem cell therapies in Arkansas. Medical doctors, osteopathic physicians, and other licensed providers with advanced training are generally authorized. Arkansas requires MD/DO licensure to administer human tissue products. Requirements may include completion of specific training related to regenerative medicine and biologics. Practitioners are encouraged to verify their eligibility through the Arkansas Medical Board to ensure they meet state qualifications.
Patient Informed Consent
Before treatment, patients must be provided with comprehensive information, including potential risks, benefits, and the experimental status of certain biologic treatments. Arkansas clinics should develop a detailed informed consent form that covers:
- A description of the procedure and its purpose
- Potential risks and benefits
- Alternative treatment options
- Disclaimers noting the experimental nature of some therapies. This consent process helps ensure that patients are fully informed and supports compliance with both state and federal standards.
Additional Requirements
Pre-Treatment and Post-Treatment Protocols
Establish clear protocols for pre-treatment and post-treatment care to ensure patient safety and treatment effectiveness. These protocols should be based on clinical guidelines and updated regularly.
Standard Operating Procedures (SOPs)
Develop and follow SOPs that cover handling, storage, and processing of biologics to maintain compliance with state and federal requirements. Written SOPs should be available for review by regulatory bodies.
Medical Liability Insurance
Arkansas clinics offering biologic therapies should secure appropriate medical liability insurance to cover risks associated with these treatments. Consulting with an insurance provider experienced in medical and regenerative medicine liability coverage is recommended.
Marketing Compliance
Marketing of biologic and stem cell therapies must be truthful and not misleading. Avoid unverified claims about the efficacy of treatments, as federal and state regulations restrict advertising that promises outcomes unsupported by clinical evidence. Refer to the FDA's guidelines on medical advertising for more information.
This guide is a general summary to help clinics understand compliance requirements for biologics in Arkansas. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.
Arkansas: common questions.
Who can administer stem cells, PRP and exosomes in Arkansas?
Are stem cell and exosome therapies FDA-approved in Arkansas?
Do I need an IRB-approved study to offer biologics in Arkansas?
How do I start offering biologics in Arkansas?
Practising in Arkansas? Start with the webinar.
Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.